Literature DB >> 27638386

Cancer Stem Cells in Squamous Cell Carcinoma.

Zhe Jian1, Alexander Strait2, Antonio Jimeno3, Xiao-Jing Wang4.   

Abstract

Cancer stem cells (CSCs) are found in many cancer types, including squamous cell carcinoma (SCC). CSCs initiate cancer formation and are linked to metastasis and resistance to therapies. Studies have revealed that several distinct CSC populations coexist in SCC and that tumor initiation and metastatic potential of these populations can be uncoupled. Therefore, it is critical to understand CSC biology to develop novel CSC-targeted therapies for patients with SCC with poor prognoses. This review compares the properties of CSCs in SCC with normal stem cells in the skin, summarizes current advances and characteristics of CSCs, and considers the challenges for CSC-targeted treatment of SCC.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27638386      PMCID: PMC5912910          DOI: 10.1016/j.jid.2016.07.033

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  105 in total

1.  Cancer incidence in indigenous people in Australia, New Zealand, Canada, and the USA: a comparative population-based study.

Authors:  Suzanne P Moore; Sébastien Antoni; Amy Colquhoun; Bonnie Healy; Lis Ellison-Loschmann; John D Potter; Gail Garvey; Freddie Bray
Journal:  Lancet Oncol       Date:  2015-10-22       Impact factor: 41.316

2.  Survival of skin cancer stem cells requires the Ezh2 polycomb group protein.

Authors:  Gautam Adhikary; Daniel Grun; Sivaprakasam Balasubramanian; Candace Kerr; Jennifer M Huang; Richard L Eckert
Journal:  Carcinogenesis       Date:  2015-05-12       Impact factor: 4.944

3.  Defining the origins of Ras/p53-mediated squamous cell carcinoma.

Authors:  Andrew C White; Kathy Tran; Joan Khuu; Christine Dang; Yongyan Cui; Scott W Binder; William E Lowry
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

4.  Enrichment for living murine keratinocytes from the hair follicle bulge with the cell surface marker CD34.

Authors:  Carol S Trempus; Rebecca J Morris; Carl D Bortner; George Cotsarelis; Randall S Faircloth; Jeffrey M Reece; Raymond W Tennant
Journal:  J Invest Dermatol       Date:  2003-04       Impact factor: 8.551

5.  Selection and adaptation during metastatic cancer progression.

Authors:  Christoph A Klein
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

6.  Expression of cancer stem cell marker during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.

Authors:  Wonbong Lim; Hongran Choi; Jisun Kim; Sangwoo Kim; Sangmi Jeon; Kou Ni; Sung-Yong Song; Hee-Kyun Oh; Yeonggwan Im; Gwangchul Lee; Jun Young Lee; Young Lae Moon; Jae Won You; Okjoon Kim
Journal:  J Mol Histol       Date:  2014-07-08       Impact factor: 2.611

7.  Control of the reversibility of cellular quiescence by the transcriptional repressor HES1.

Authors:  Liyun Sang; Hilary A Coller; James M Roberts
Journal:  Science       Date:  2008-08-22       Impact factor: 47.728

8.  Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin.

Authors:  Iñigo Martincorena; Amit Roshan; Moritz Gerstung; Peter Ellis; Peter Van Loo; Stuart McLaren; David C Wedge; Anthony Fullam; Ludmil B Alexandrov; Jose M Tubio; Lucy Stebbings; Andrew Menzies; Sara Widaa; Michael R Stratton; Philip H Jones; Peter J Campbell
Journal:  Science       Date:  2015-05-22       Impact factor: 47.728

9.  The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma.

Authors:  R Banerjee; R-S Mani; N Russo; C S Scanlon; A Tsodikov; X Jing; Q Cao; N Palanisamy; T Metwally; R C Inglehart; S Tomlins; C Bradford; T Carey; G Wolf; S Kalyana-Sundaram; A M Chinnaiyan; S Varambally; N J D'Silva
Journal:  Oncogene       Date:  2011-05-02       Impact factor: 9.867

10.  MicroRNA-205 controls neonatal expansion of skin stem cells by modulating the PI(3)K pathway.

Authors:  Dongmei Wang; Zhaojie Zhang; Evan O'Loughlin; Li Wang; Xiying Fan; Eric C Lai; Rui Yi
Journal:  Nat Cell Biol       Date:  2013-08-25       Impact factor: 28.824

View more
  9 in total

1.  EZH2 regulates a SETDB1/ΔNp63α axis via RUNX3 to drive a cancer stem cell phenotype in squamous cell carcinoma.

Authors:  Seamus Balinth; Matthew L Fisher; Yon Hwangbo; Caizhi Wu; Carlos Ballon; Xueqin Sun; Alea A Mills
Journal:  Oncogene       Date:  2022-07-21       Impact factor: 8.756

2.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

3.  HOTAIR/Sp1/miR-199a critically regulates cancer stemness and malignant progression of cutaneous squamous cell carcinoma.

Authors:  Jia Chen; Shu-Fen Hou; Feng-Jie Tang; Dai-Song Liu; Zi-Zi Chen; Hong-Lian Zhang; Shao-Hua Wang
Journal:  Oncogene       Date:  2021-10-25       Impact factor: 9.867

Review 4.  Current and Future Perspectives of Stem Cell Therapy in Dermatology.

Authors:  Christine M Prodinger; Julia Reichelt; Johann W Bauer; Martin Laimer
Journal:  Ann Dermatol       Date:  2017-10-30       Impact factor: 1.444

5.  A comprehensive analysis of coding and non-coding transcriptomic changes in cutaneous squamous cell carcinoma.

Authors:  Kunal Das Mahapatra; Lorenzo Pasquali; Jonas Nørskov Søndergaard; Jan Lapins; István Balazs Nemeth; Eszter Baltás; Lajos Kemény; Bernhard Homey; Liviu-Ionut Moldovan; Jørgen Kjems; Claudia Kutter; Enikö Sonkoly; Lasse Sommer Kristensen; Andor Pivarcsi
Journal:  Sci Rep       Date:  2020-02-27       Impact factor: 4.379

6.  Comprehensive analysis of lncRNA-mRNAs co-expression network identifies potential lncRNA biomarkers in cutaneous squamous cell carcinoma.

Authors:  Yu Hu; Rong Li; Hongyin Chen; Lihao Chen; Xuyue Zhou; Linxi Liu; Mei Ju; Kun Chen; Dan Huang
Journal:  BMC Genomics       Date:  2022-04-07       Impact factor: 3.969

Review 7.  The Contributions of Cancer-Testis and Developmental Genes to the Pathogenesis of Keratinocyte Carcinomas.

Authors:  Brandon Ramchatesingh; Jennifer Gantchev; Amelia Martínez Villarreal; Raman Preet Kaur Gill; Marine Lambert; Sriraam Sivachandran; Philippe Lefrançois; Ivan V Litvinov
Journal:  Cancers (Basel)       Date:  2022-07-26       Impact factor: 6.575

Review 8.  Stem Cells as a Target for the Delivery of Active Molecules to Skin by Topical Administration.

Authors:  Hamid-Reza Ahmadi-Ashtiani; Parisa Bishe; Anna Baldisserotto; Piergiacomo Buso; Stefano Manfredini; Silvia Vertuani
Journal:  Int J Mol Sci       Date:  2020-03-24       Impact factor: 5.923

9.  miR-22 promotes stem cell traits via activating Wnt/β-catenin signaling in cutaneous squamous cell carcinoma.

Authors:  Shukai Yuan; Peitao Zhang; Liqi Wen; Shikai Jia; Yufan Wu; Zhenlei Zhang; Lizhao Guan; Zhengquan Yu; Li Zhao
Journal:  Oncogene       Date:  2021-08-03       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.